556 related articles for article (PubMed ID: 28641496)
1. Guanfacine Attenuates Adverse Effects of Dronabinol (THC) on Working Memory in Adolescent-Onset Heavy Cannabis Users: A Pilot Study.
Mathai DS; Holst M; Rodgman C; Haile CN; Keller J; Hussain MZ; Kosten TR; Newton TF; Verrico CD
J Neuropsychiatry Clin Neurosci; 2018; 30(1):66-76. PubMed ID: 28641496
[TBL] [Abstract][Full Text] [Related]
2. The effect of five day dosing with THCV on THC-induced cognitive, psychological and physiological effects in healthy male human volunteers: A placebo-controlled, double-blind, crossover pilot trial.
Englund A; Atakan Z; Kralj A; Tunstall N; Murray R; Morrison P
J Psychopharmacol; 2016 Feb; 30(2):140-51. PubMed ID: 26577065
[TBL] [Abstract][Full Text] [Related]
3. Cognitive and psychomotor effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg delta-9-tetrahydrocannabinol (THC).
Hunault CC; Mensinga TT; Böcker KB; Schipper CM; Kruidenier M; Leenders ME; de Vries I; Meulenbelt J
Psychopharmacology (Berl); 2009 May; 204(1):85-94. PubMed ID: 19099294
[TBL] [Abstract][Full Text] [Related]
4. Alpha-2 adrenergic challenge with guanfacine one month after mild traumatic brain injury: altered working memory and BOLD response.
McAllister TW; McDonald BC; Flashman LA; Ferrell RB; Tosteson TD; Yanofsky NN; Grove MR; Saykin AJ
Int J Psychophysiol; 2011 Oct; 82(1):107-14. PubMed ID: 21767584
[TBL] [Abstract][Full Text] [Related]
5. Guanfacine ameliorates hypobaric hypoxia induced spatial working memory deficits.
Kauser H; Sahu S; Kumar S; Panjwani U
Physiol Behav; 2014 Jan; 123():187-92. PubMed ID: 24184415
[TBL] [Abstract][Full Text] [Related]
6. Assessment of Orally Administered Δ9-Tetrahydrocannabinol When Coadministered With Cannabidiol on Δ9-Tetrahydrocannabinol Pharmacokinetics and Pharmacodynamics in Healthy Adults: A Randomized Clinical Trial.
Zamarripa CA; Spindle TR; Surujunarain R; Weerts EM; Bansal S; Unadkat JD; Paine MF; Vandrey R
JAMA Netw Open; 2023 Feb; 6(2):e2254752. PubMed ID: 36780161
[TBL] [Abstract][Full Text] [Related]
7. The safety of modafinil in combination with oral ∆9-tetrahydrocannabinol in humans.
Sugarman DE; Poling J; Sofuoglu M
Pharmacol Biochem Behav; 2011 Mar; 98(1):94-100. PubMed ID: 21176784
[TBL] [Abstract][Full Text] [Related]
8. Delta-9-tetrahydrocannabinol intoxication is associated with increased prefrontal activation as assessed with functional near-infrared spectroscopy: A report of a potential biomarker of intoxication.
Gilman JM; Yücel MA; Pachas GN; Potter K; Levar N; Broos H; Manghis EM; Schuster RM; Evins AE
Neuroimage; 2019 Aug; 197():575-585. PubMed ID: 31075393
[TBL] [Abstract][Full Text] [Related]
9. The effect of high-dose dronabinol (oral THC) maintenance on cannabis self-administration.
Schlienz NJ; Lee DC; Stitzer ML; Vandrey R
Drug Alcohol Depend; 2018 Jun; 187():254-260. PubMed ID: 29689485
[TBL] [Abstract][Full Text] [Related]
10. Cannabis with high δ9-THC contents affects perception and visual selective attention acutely: an event-related potential study.
Böcker KB; Gerritsen J; Hunault CC; Kruidenier M; Mensinga TT; Kenemans JL
Pharmacol Biochem Behav; 2010 Jul; 96(1):67-74. PubMed ID: 20417659
[TBL] [Abstract][Full Text] [Related]
11. Acute subjective effects after smoking joints containing up to 69 mg Δ9-tetrahydrocannabinol in recreational users: a randomized, crossover clinical trial.
Hunault CC; Böcker KB; Stellato RK; Kenemans JL; de Vries I; Meulenbelt J
Psychopharmacology (Berl); 2014 Dec; 231(24):4723-33. PubMed ID: 24879495
[TBL] [Abstract][Full Text] [Related]
12. Guanfacine decreases symptoms of cannabis withdrawal in daily cannabis smokers.
Haney M; Cooper ZD; Bedi G; Herrmann E; Comer SD; Reed SC; Foltin RW; Levin FR
Addict Biol; 2019 Jul; 24(4):707-716. PubMed ID: 29659126
[TBL] [Abstract][Full Text] [Related]
13. Tolerance and cross-tolerance to neurocognitive effects of THC and alcohol in heavy cannabis users.
Ramaekers JG; Theunissen EL; de Brouwer M; Toennes SW; Moeller MR; Kauert G
Psychopharmacology (Berl); 2011 Mar; 214(2):391-401. PubMed ID: 21049267
[TBL] [Abstract][Full Text] [Related]
14. Acute memory and psychotomimetic effects of cannabis and tobacco both 'joint' and individually: a placebo-controlled trial.
Hindocha C; Freeman TP; Xia JX; Shaban NDC; Curran HV
Psychol Med; 2017 Nov; 47(15):2708-2719. PubMed ID: 28558859
[TBL] [Abstract][Full Text] [Related]
15. Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: a randomised, double-blind, placebo-controlled study in cannabis users.
Hindocha C; Freeman TP; Schafer G; Gardener C; Das RK; Morgan CJ; Curran HV
Eur Neuropsychopharmacol; 2015 Mar; 25(3):325-34. PubMed ID: 25534187
[TBL] [Abstract][Full Text] [Related]
16. Acute effects of oral delta-9-tetrahydrocannabinol (THC) on autonomic cardiac activity and their relation to subjective and anxiogenic effects.
Pabon E; Rockwood F; Norman GJ; de Wit H
Psychophysiology; 2022 Feb; 59(2):e13955. PubMed ID: 34665890
[TBL] [Abstract][Full Text] [Related]
17. Use of Guanfacine for Cannabis Use Disorder and Related Symptomology.
Holst M; Mathai DS; Patel MM; Rodgman C; Keller J; Hussain MZ; De La Garza R; Kosten TR; Verrico CD
Am J Addict; 2019 Nov; 28(6):455-464. PubMed ID: 31483544
[TBL] [Abstract][Full Text] [Related]
18. Extended-Release Guanfacine for Hyperactivity in Children With Autism Spectrum Disorder.
Scahill L; McCracken JT; King BH; Rockhill C; Shah B; Politte L; Sanders R; Minjarez M; Cowen J; Mullett J; Page C; Ward D; Deng Y; Loo S; Dziura J; McDougle CJ;
Am J Psychiatry; 2015 Dec; 172(12):1197-206. PubMed ID: 26315981
[TBL] [Abstract][Full Text] [Related]
19. The acute effects of cannabis with and without cannabidiol in adults and adolescents: A randomised, double-blind, placebo-controlled, crossover experiment.
Lawn W; Trinci K; Mokrysz C; Borissova A; Ofori S; Petrilli K; Bloomfield M; Haniff ZR; Hall D; Fernandez-Vinson N; Wang S; Englund A; Chesney E; Wall MB; Freeman TP; Curran HV
Addiction; 2023 Jul; 118(7):1282-1294. PubMed ID: 36750134
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the subjective effects of Delta(9)-tetrahydrocannabinol and marijuana in humans.
Wachtel SR; ElSohly MA; Ross SA; Ambre J; de Wit H
Psychopharmacology (Berl); 2002 Jun; 161(4):331-9. PubMed ID: 12073159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
